164 related articles for article (PubMed ID: 31315397)
1. MoS
Singh AK; Mishra H; Firdaus Z; Yadav S; Aditi P; Nandy N; Sharma K; Bose P; Pandey AK; Chauhan BS; Neogi K; Vikram K; Srivastava A; Kar AG; Prakash P
Chem Res Toxicol; 2019 Aug; 32(8):1599-1618. PubMed ID: 31315397
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial, antibiofilm, and antiquorum sensing activities of phytosynthesized silver nanoparticles fabricated from Mespilus germanica extract against multidrug resistance of Klebsiella pneumoniae clinical strains.
Foroohimanjili F; Mirzaie A; Hamdi SMM; Noorbazargan H; Hedayati Ch M; Dolatabadi A; Rezaie H; Bishak FM
J Basic Microbiol; 2020 Mar; 60(3):216-230. PubMed ID: 31994223
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and antibiofilm efficacy of Ag NPs, Ni NPs and Al
Edhari BA; Mashreghi M; Makhdoumi A; Darroudi M
J Trace Elem Med Biol; 2021 Dec; 68():126840. PubMed ID: 34425454
[TBL] [Abstract][Full Text] [Related]
4. Characterization of virulence factors and antibacterial activity of curcumin in hypervirulent
Karami-Zarandi M; Ghale HE; Ranjbar R
Future Microbiol; 2022 May; 17():529-540. PubMed ID: 35322691
[No Abstract] [Full Text] [Related]
5. Antimicrobial polymers as therapeutics for treatment of multidrug-resistant Klebsiella pneumoniae lung infection.
Lou W; Venkataraman S; Zhong G; Ding B; Tan JPK; Xu L; Fan W; Yang YY
Acta Biomater; 2018 Sep; 78():78-88. PubMed ID: 30031912
[TBL] [Abstract][Full Text] [Related]
6. Liquid-Phase Exfoliation and Functionalization of MoS
Ma D; Xie C; Wang T; Mei L; Zhang X; Guo Z; Yin W
Chembiochem; 2020 Aug; 21(16):2373-2380. PubMed ID: 32227558
[TBL] [Abstract][Full Text] [Related]
7.
Yu F; Lv J; Niu S; Du H; Tang YW; Bonomo RA; Kreiswirth BN; Chen L
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891605
[TBL] [Abstract][Full Text] [Related]
8. Rhenium and yttrium ions as antimicrobial agents against multidrug resistant Klebsiella pneumoniae and Acinetobacter baumannii biofilms.
Slate AJ; Shalamanova L; Akhidime ID; Whitehead KA
Lett Appl Microbiol; 2019 Sep; 69(3):168-174. PubMed ID: 30929272
[TBL] [Abstract][Full Text] [Related]
9. The antibacterial activities of MoS
Zhao Y; Jia Y; Xu J; Han L; He F; Jiang X
Chem Commun (Camb); 2021 Mar; 57(24):2998-3001. PubMed ID: 33621298
[TBL] [Abstract][Full Text] [Related]
10. ASK2 Bioactive Compound Inhibits MDR
Lalitha C; Raman T; Rathore SS; Ramar M; Munusamy A; Ramakrishnan J
Front Cell Infect Microbiol; 2017; 7():346. PubMed ID: 28824881
[TBL] [Abstract][Full Text] [Related]
11. Combination of essential oil and ciprofloxacin to inhibit/eradicate biofilms in multidrug-resistant Klebsiella pneumoniae.
Mohamed SH; Mohamed MSM; Khalil MS; Azmy M; Mabrouk MI
J Appl Microbiol; 2018 Jul; 125(1):84-95. PubMed ID: 29517825
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of biopolymer polyhydroxyalkanoate/chitosan and 2D molybdenum disulfide-doped scaffolds for antibacterial and biomedical applications.
Mukheem A; Shahabuddin S; Akbar N; Anwar A; Sarih NM; Sudesh K; Khan NA; Sridewi N
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3121-3131. PubMed ID: 32060693
[TBL] [Abstract][Full Text] [Related]
13. Promising strategies for future treatment of
de Oliveira Júnior NG; Franco OL
Future Microbiol; 2020 Jan; 15():63-79. PubMed ID: 32048525
[No Abstract] [Full Text] [Related]
14. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.
Li W; Sun G; Yu Y; Li N; Chen M; Jin R; Jiao Y; Wu H
Clin Infect Dis; 2014 Jan; 58(2):225-32. PubMed ID: 24099919
[TBL] [Abstract][Full Text] [Related]
15. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China.
Zhang Y; Zeng J; Liu W; Zhao F; Hu Z; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Li S; Cao B; Wang H
J Infect; 2015 Nov; 71(5):553-60. PubMed ID: 26304687
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a Multidrug-Resistant Hypervirulent Klebsiella pneumoniae Sequence Type 23 Strain with a Rare
Shen D; Ma G; Li C; Jia X; Qin C; Yang T; Wang L; Jiang X; Ding N; Zhang X; Yue L; Yin Z; Zeng L; Zhao Y; Zhou D; Chen F
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602516
[TBL] [Abstract][Full Text] [Related]
17. The Determination and Correlation of Various Virulence Genes, ESBL, Serum Bactericidal Effect and Biofilm Formation of Clinical Isolated Classical Klebsiella pneumoniae and Hypervirulent Klebsiella pneumoniae from Respiratory Tract Infected Patients.
Shah RK; Ni ZH; Sun XY; Wang GQ; Li F
Pol J Microbiol; 2017 Dec; 66(4):501-508. PubMed ID: 29319515
[TBL] [Abstract][Full Text] [Related]
18. Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.
Ribeiro SM; de la Fuente-Núñez C; Baquir B; Faria-Junior C; Franco OL; Hancock RE
Antimicrob Agents Chemother; 2015 Jul; 59(7):3906-12. PubMed ID: 25896694
[TBL] [Abstract][Full Text] [Related]
19. From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria.
Hammad A; Abutaleb NS; Elsebaei MM; Norvil AB; Alswah M; Ali AO; Abdel-Aleem JA; Alattar A; Bayoumi SA; Gowher H; Seleem MN; Mayhoub AS
J Med Chem; 2019 Sep; 62(17):7998-8010. PubMed ID: 31369262
[TBL] [Abstract][Full Text] [Related]
20. Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China.
Yao B; Xiao X; Wang F; Zhou L; Zhang X; Zhang J
Int J Infect Dis; 2015 Aug; 37():107-12. PubMed ID: 26141415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
